```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1237 Reported in House (RH)]

                                                 Union Calendar No. 348
110th CONGRESS
  2d Session
                                H. R. 1237

                          [Report No. 110-566]

To amend the Public Health Service Act to provide revised standards for 
 quality assurance in screening and evaluation of gynecologic cytology 
                 preparations, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 28, 2007

 Mr. Gordon of Tennessee (for himself, Mr. Price of Georgia, Ms. Foxx, 
 Ms. Herseth, and Mr. Deal of Georgia) introduced the following bill; 
       which was referred to the Committee on Energy and Commerce

                             April 8, 2008

 Additional sponsors: Mr. Rogers of Michigan, Mr. Burgess, Mr. Cohen, 
 Mr. English of Pennsylvania, Mr. Jefferson, Mr. Boucher, Mrs. Myrick, 
Mr. Gene Green of Texas, Mr. Holden, Ms. Hooley, Mr. Burton of Indiana, 
  Mr. Shuster, Mr. Hinojosa, Mr. McNulty, Mr. Shimkus, Mr. Weldon of 
  Florida, Mr. Boustany, Mr. Gonzalez, Mr. Boswell, Mr. Sullivan, Ms. 
Baldwin, Mr. Doyle, Mr. Latham, Mr. Ryan of Wisconsin, Mr. Bonner, Mr. 
Neal of Massachusetts, Mrs. Cubin, Mr. Coble, Mr. Paul, Mr. Tim Murphy 
  of Pennsylvania, Mr. Pitts, Mr. Young of Alaska, Mr. David Davis of 
   Tennessee, Mrs. Maloney of New York, Mr. Rothman, Mr. Sires, Mr. 
   Gingrey, Mrs. McCarthy of New York, Mr. Pickering, Mr. Wynn, Mr. 
 McGovern, Ms. Roybal-Allard, Mr. Weiner, Mrs. Blackburn, Mr. Snyder, 
 Ms. DeGette, Mr. Moran of Virginia, Ms. Eshoo, Mr. Butterfield, Mrs. 
     Capps, Mr. Carnahan, Mr. Hare, Mrs. Bono Mack, Mr. Renzi, Mr. 
Abercrombie, Mr. Platts, Mr. Allen, Mr. Hill, Mr. Ross, Ms. Harman, Mr. 
Buyer, Mr. Ramstad, Ms. Woolsey, Mr. Donnelly, Mr. Kildee, Mr. Hall of 
Texas, Mr. Higgins, Mr. Lincoln Diaz-Balart of Florida, Ms. Slaughter, 
 Mr. Baird, Mr. Ferguson, Mrs. Wilson of New Mexico, Mr. Manzullo, Mr. 
Braley of Iowa, Mr. Engel, Mr. Berry, Mr. Boozman, Mr. Wolf, Mr. Payne, 
Mr. Fortuno, Mr. Davis of Illinois, Mr. Terry, Mr. Kind, Mr. Melancon, 
 Mrs. Jo Ann Davis of Virginia, Mr. Nadler, Mr. Herger, Mr. Kagen, Mr. 
    Reynolds, Mr. Altmire, Mr. Hinchey, Mr. Kennedy, Mr. Levin, Ms. 
 Schakowsky, Mr. Radanovich, Mr. Bilirakis, Mr. Fossella, Mr. Markey, 
Mr. Lewis of Georgia, Mr. Tiberi, Mr. Barrow, Mr. Pascrell, Mr. Castle, 
 Mr. Upton, Ms. Solis, Mr. Issa, Ms. Kaptur, Mr. Hall of New York, Mr. 
 Whitfield of Kentucky, Mr. Meek of Florida, Mr. Langevin, Mr. Inslee, 
      Mr. Waxman, Mr. Matheson, Mr. Thompson of Mississippi, Mr. 
  Sensenbrenner, Mr. King of New York, Mr. Courtney, Ms. Berkley, Mr. 
 Petri, Mr. Larson of Connecticut, Mr. Scott of Georgia, Ms. Schwartz, 
  Mr. Kirk, Mr. Udall of New Mexico, Mr. Towns, Mr. Camp of Michigan, 
Mrs. Boyda of Kansas, Mr. Stupak, Ms. Ginny Brown-Waite of Florida, Mr. 
Berman, Ms. Zoe Lofgren of California, Mr. Walden of Oregon, Mr. Bishop 
  of Georgia, Mr. Johnson of Illinois, Mr. Costello, Mr. Calvert, Ms. 
Richardson, Mr. Stearns, Mr. Olver, Mr. Walsh of New York, Mr. Al Green 
  of Texas, Mrs. Gillibrand, Mr. LoBiondo, Mr. Kuhl of New York, Mr. 
Brady of Pennsylvania, Mr. McIntyre, Mr. Welch of Vermont, Mr. Shadegg, 
  Mr. Buchanan, Mrs. Christensen, Mr. Dent, Ms. Sutton, Mrs. Jones of 
 Ohio, Mr. Shays, Mr. Fattah, Ms. Moore of Wisconsin, Ms. DeLauro, Mr. 
   Porter, Mr. Murphy of Connecticut, Mr. Sam Johnson of Texas, Ms. 
 Clarke, Mr. Lynch, Mr. Rush, Mr. LaTourette, Mr. Ehlers, Ms. Tsongas, 
        Mr. Hoekstra, Mr. Boren, Mr. Feeney, and Ms. Shea-Porter

                             April 8, 2008

  Reported with an amendment, committed to the Committee of the Whole 
       House on the State of the Union, and ordered to be printed
 [Strike out all after the enacting clause and insert the part printed 
                               in italic]

_______________________________________________________________________

                                 A BILL

 
To amend the Public Health Service Act to provide revised standards for 
 quality assurance in screening and evaluation of gynecologic cytology 
                 preparations, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

<DELETED>SECTION 1. SHORT TITLE.</DELETED>

<DELETED>    This Act may be cited as the ``Cytology Proficiency 
Improvement Act of 2007''.</DELETED>

<DELETED>SEC. 2. REVISED STANDARDS FOR QUALITY ASSURANCE IN SCREENING 
              AND EVALUATION OF GYNECOLOGIC CYTOLOGY 
              PREPARATIONS.</DELETED>

<DELETED>    (a) In General.--Section 353(f)(4)(B)(iv) of the Public 
Health Service Act (42 U.S.C. 263a(f)(4)(B)(iv)) is amended to read as 
follows:</DELETED>
                        <DELETED>    ``(iv) requirements that each 
                        clinical laboratory--</DELETED>
                                <DELETED>    ``(I) ensure that all 
                                individuals involved in screening and 
                                interpreting cytological preparations 
                                at the laboratory participate annually 
                                in a continuing medical education 
                                program in gynecologic cytology that--
                                </DELETED>
                                        <DELETED>    ``(aa) is approved 
                                        by the Accrediting Council for 
                                        Continuing Medical Education or 
                                        the American Academy of 
                                        Continuing Medical Education, 
                                        and</DELETED>
                                        <DELETED>    ``(bb) provides 
                                        each individual participating 
                                        in the program with gynecologic 
                                        cytologic preparations (in the 
                                        form of referenced glass slides 
                                        or equivalent technologies) 
                                        designed to improve the 
                                        locator, recognition and 
                                        interpretive skills of the 
                                        individual, and</DELETED>
                                <DELETED>    ``(II) maintain a record 
                                of the cytology continuing medical 
                                education results of each individual 
                                involved in screening and interpreting 
                                cytological preparations at the 
                                laboratory,''.</DELETED>
<DELETED>    (b) Effective Date and Implementation; Termination of 
Current Program of Individual Proficiency Testing.--</DELETED>
        <DELETED>    (1) Effective date and implementation.--Except as 
        provided in paragraph (2), the amendment made by subsection (a) 
        applies to gynecologic cytology services provided on or after 
        the date that is one year after the date of the enactment of 
        this Act, and the Secretary of Health and Human Services 
        (hereafter in this subsection referred to as the ``Secretary'') 
        shall issue final regulations implementing such amendment not 
        later than 270 days after such date of enactment.</DELETED>
        <DELETED>    (2) Termination of current individual proficiency 
        testing program.--As of the date of the enactment of this Act, 
        the Secretary shall terminate the individual proficiency 
        testing program established pursuant to section 
        353(f)(4)(B)(iv) of the Public Health Service Act (42 U.S.C. 
        263a(f)(4)(B)(iv)), as in effect before the enactment of this 
        section.</DELETED>

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Cytology Proficiency Improvement Act 
of 2008''.

SEC. 2. REVISED STANDARDS FOR QUALITY ASSURANCE IN SCREENING AND 
              EVALUATION OF GYNECOLOGIC CYTOLOGY PREPARATIONS.

    (a) In General.--Section 353(f)(4)(B)(iv) of the Public Health 
Service Act (42 U.S.C. 263a(f)(4)(B)(iv)) is amended to read as 
follows:
                            ``(iv) requirements that each clinical 
                        laboratory--
                                    ``(I) ensure that all individuals 
                                involved in screening and interpreting 
                                cytological preparations at the 
                                laboratory participate annually in a 
                                continuing medical education program in 
                                gynecologic cytology that--
                                            ``(aa) is approved by the 
                                        Accrediting Council for 
                                        Continuing Medical Education or 
                                        the American Academy of 
                                        Continuing Medical Education; 
                                        and
                                            ``(bb) provides each 
                                        individual participating in the 
                                        program with gynecologic 
                                        cytological preparations (in 
                                        the form of referenced glass 
                                        slides or equivalent 
                                        technologies) designed to 
                                        improve the locator, 
                                        recognition, and interpretive 
                                        skills of the individual;
                                    ``(II) maintain a record of the 
                                cytology continuing medical education 
                                program results for each individual 
                                involved in screening and interpreting 
                                cytological preparations at the 
                                laboratory;
                                    ``(III) provide that the laboratory 
                                director shall take into account such 
                                results and other performance metrics 
                                in reviewing the performance of 
                                individuals involved in screening and 
                                interpreting cytological preparations 
                                at the laboratory and, when necessary, 
                                identify needs for remedial training or 
                                a corrective action plan to improve 
                                skills; and
                                    ``(IV) submit the continuing 
                                education program results for each 
                                individual and, if appropriate, plans 
                                for corrective action or remedial 
                                training in a timely manner to the 
                                laboratory's accrediting organization 
                                for purposes of review and on-going 
                                monitoring by the accrediting 
                                organization, including reviews of the 
                                continuing medical education program 
                                results during on-site inspections of 
                                the laboratory.''.
    (b) Effective Date and Implementation; Termination of Current 
Program of Individual Proficiency Testing.--
            (1) Effective date and implementation.--Except as provided 
        in paragraph (2), the amendment made by subsection (a) applies 
        to gynecologic cytology services provided on or after the first 
        day of the first calendar year beginning 1 year or more after 
        the date of the enactment of this Act, and the Secretary of 
        Health and Human Services (hereafter in this subsection 
        referred to as the ``Secretary'') shall issue final regulations 
        implementing such amendment not later than 270 days after such 
        date of enactment.
            (2) Termination of current individual testing program.--The 
        Secretary of Health and Human Services shall terminate the 
        individual proficiency testing program established pursuant to 
        section 353(f)(4)(B)(iv) of the Public Health Service Act (42 
        U.S.C. 263a(f)(4)(B)(iv)), as in effect on the day before the 
        date of the enactment of subsection (a), at the end of the 
        calendar year which includes the date of enactment of the 
        amendment made by subsection (a).
                                                 Union Calendar No. 348

110th CONGRESS

  2d Session

                               H. R. 1237

                          [Report No. 110-566]

_______________________________________________________________________

                                 A BILL

To amend the Public Health Service Act to provide revised standards for 
 quality assurance in screening and evaluation of gynecologic cytology 
                 preparations, and for other purposes.

_______________________________________________________________________

                             April 8, 2008

  Reported with an amendment, committed to the Committee of the Whole 
       House on the State of the Union, and ordered to be printed
```